Is Hemodialysis Used for Methotrexate Toxicity and AKI?
At a Glance
Hemodialysis is not routinely used just to remove methotrexate. It may be lifesaving when acute kidney injury causes uncontrolled potassium, severe acid buildup, or fluid in the lungs, or when glucarpidase is unavailable; kidney recovery is often possible.
In this answer
3 sections
Urgent Action: If you are receiving or have recently received high-dose methotrexate and experience markedly reduced urine output, new swelling, shortness of breath, severe vomiting, or confusion, contact your oncology team or emergency services immediately. Do not attempt to manage these symptoms or increase your fluid intake at home.
If you develop acute kidney injury (a sudden decline in kidney function) from high-dose methotrexate therapy, you will not automatically need hemodialysis. Hemodialysis is not routinely used simply to clear methotrexate from the body, because standard medical treatments are typically much faster and more effective [1]. However, your care team or a nephrologist (kidney specialist) may urgently recommend dialysis if your kidneys cannot manage fluids and electrolytes, leading to life-threatening complications [2].
How Methotrexate Toxicity is Usually Treated
When methotrexate causes delayed clearance and kidney injury, the primary goal is to protect the kidneys, clear the drug, and rescue healthy cells. This is managed urgently in a hospital setting.
| Treatment | Main Purpose | When It Is Used | Limitations |
|---|---|---|---|
| IV Hydration & Alkalinization | Supports kidney excretion and prevents drug crystals. | Standard care during and after high-dose methotrexate. | Requires close monitoring to avoid fluid overload if kidneys are failing. |
| Leucovorin | Rescues healthy cells from methotrexate toxicity. | Standard care after high-dose methotrexate. | Does not remove methotrexate from the body. |
| Glucarpidase | Rapidly breaks down circulating methotrexate. | When methotrexate levels are dangerously high and kidneys are impaired. | Does not remove drug stored in tissues; requires specialized blood tests afterward. |
| Hemodialysis / CRRT | Replaces kidney function and manages severe complications. | When dangerous fluid or electrolyte imbalances occur, or glucarpidase is unavailable. | Can remove leucovorin; drug levels may rebound after sessions. |
Hydration and Alkalinization
You will receive highly monitored intravenous (IV) fluids to support your kidneys [3]. This fluid is often “alkalinized” (made less acidic) using sodium bicarbonate. Alkalinization helps prevent methotrexate from forming crystals that block and damage the kidney filters [3] [4]. Do not drink excess fluids on your own, as this can cause dangerous fluid buildup in your lungs or body if your kidneys are not producing enough urine.
Leucovorin (Folinic Acid) Rescue
Leucovorin is a specialized form of vitamin B9 that protects healthy cells from the toxic effects of methotrexate [3]. While it does not clear methotrexate from the body, high doses of leucovorin are given at specific times to neutralize the drug’s impact [4].
Glucarpidase
If your kidneys are impaired and methotrexate levels remain dangerously high, doctors may administer an enzyme called glucarpidase. Glucarpidase rapidly breaks down circulating methotrexate into less toxic metabolites, reducing blood levels by roughly 97% to 99% within 15 minutes [5]. Because glucarpidase can also break down leucovorin, your oncology team will carefully time these medications [5]. After receiving glucarpidase, standard blood tests can falsely show high methotrexate levels, so hospitals often need to use a specialized test (mass spectrometry) to measure the true amount of the drug remaining [6].
When is Hemodialysis or CRRT Used?
Dialysis uses a machine to filter waste, toxins, and excess fluid from your blood. Expert guidelines recommend against using routine dialysis solely to clear methotrexate if glucarpidase is available [1]. Dialysis mainly removes methotrexate from the blood vessels, but the drug heavily distributes into your body’s tissues [1].
However, blood filtering may be used in specific, critical situations:
- Dangerous Kidney Complications: If acute kidney injury leads to refractory hyperkalemia (dangerously high potassium), severe acid imbalances, or fluid buildup in the lungs, dialysis is a standard, lifesaving treatment to take over the kidney’s job [2].
- Glucarpidase is Unavailable: If a hospital does not have glucarpidase or its administration is significantly delayed, high-flux hemodialysis may be used to help lower methotrexate levels [7].
- Continuous Renal Replacement Therapy (CRRT): For critically ill patients who have unstable blood pressure and cannot tolerate standard intermittent hemodialysis, doctors may use CRRT [8]. CRRT provides slower, continuous, 24-hour kidney support [9]. It is chosen to safely support the patient’s physiology, though it is not proven to be superior at clearing methotrexate itself [10].
If dialysis is used to remove methotrexate, patients often require repeated sessions [7]. Because methotrexate distributes into tissues, it can seep back into the bloodstream after a dialysis session ends—a phenomenon known as the “rebound” effect [7] [11].
Kidney Recovery and Follow-Up
It is normal to be frightened by the prospect of kidney damage or dialysis. However, needing temporary dialysis does not inherently mean you have permanent kidney failure. In many cases of methotrexate toxicity, acute kidney injury is reversible. Studies in severe cases have shown that kidney function commonly returns to normal or near-normal within 3 to 6 weeks, though recovery can sometimes take longer or be incomplete depending on your baseline health [7] [12].
After the acute crisis resolves, your care team will continue to monitor your creatinine levels, electrolytes, and blood pressure to evaluate your kidney recovery. Avoid starting or restarting any NSAIDs (like ibuprofen), antibiotics, acid-suppressing medicines, or supplements without explicit clearance from your oncology team, as these can interfere with kidney recovery and methotrexate clearance.
Common questions in this guide
Is dialysis routinely used to remove methotrexate from the body?
When might hemodialysis be necessary after methotrexate treatment?
What is CRRT, and why might it be used for methotrexate toxicity?
What treatments are used for methotrexate toxicity with acute kidney injury?
Does needing temporary dialysis mean methotrexate caused permanent kidney failure?
Which symptoms of methotrexate kidney injury require urgent help?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What are my current methotrexate levels, and are they falling as expected?
- 2.What is my creatinine and urine output trend, and do we need to consult a nephrologist?
- 3.Do I meet the criteria for glucarpidase treatment based on my current labs?
- 4.If glucarpidase is given, is the laboratory equipped to measure my true methotrexate levels afterward using mass spectrometry?
- 5.What specific complications, such as fluid overload or electrolyte imbalances, would make dialysis necessary for me?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (12)
- 1
Extracorporeal Treatment for Methotrexate Poisoning: Systematic Review and Recommendations from the EXTRIP Workgroup.
Ghannoum M, Roberts DM, Goldfarb DS, et al.
Clinical journal of the American Society of Nephrology : CJASN 2022; (17(4)):602-622 doi:10.2215/CJN.08030621.
PMID: 35236714 - 2
Extracorporeal management of severe methotrexate toxicity and acute kidney injury in the absence of glucarpidase.
Purzycki T, Knapp M, Patel S
BMJ case reports 2025; (18(12)) doi:10.1136/bcr-2025-267929.
PMID: 41397779 - 3
Preventing and Managing Toxicities of High-Dose Methotrexate.
Howard SC, McCormick J, Pui CH, et al.
The oncologist 2016; (21(12)):1471-1482 doi:10.1634/theoncologist.2015-0164.
PMID: 27496039 - 4
The effect of leucovorin rescue therapy on methotrexate-induced oral mucositis in the treatment of paediatric ALL: A systematic review.
Van der Beek JN, Oosterom N, Pieters R, et al.
Critical reviews in oncology/hematology 2019; (142()):1-8 doi:10.1016/j.critrevonc.2019.07.003.
PMID: 31323533 - 5
A pooled subgroup analysis of glucarpidase treatment in 86 pediatric, adolescent, and young adult patients receiving high-dose methotrexate therapy in open-label trials.
Janeway KA, Gros L, Schwartz S, et al.
Pediatric blood & cancer 2023; e30506 doi:10.1002/pbc.30506.
PMID: 37369988 - 6
DAMPAned Methotrexate: A Case Report and Review of the Management of Acute Methotrexate Toxicity.
Young A, Beriault D, Jung B, et al.
Canadian journal of kidney health and disease 2019; (6()):2054358119895078 doi:10.1177/2054358119895078.
PMID: 31903191 - 7
Effective elimination of high-dose methotrexate by repeated hemodiafiltration and high-flux hemodialysis in patients with acute kidney injury.
Sakran R, Milo G, Jabareen A, et al.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 2022; (28(2)):508-515 doi:10.1177/10781552211052564.
PMID: 34668443 - 8
Renal Replacement Therapy in Adult Intensive Care Unit: An ISCCM Expert Panel Practice Recommendation.
Mishra RC, Sinha S, Govil D, et al.
Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine 2022; (26(Suppl 2)):S3-S6 doi:10.5005/jp-journals-10071-24278.
PMID: 36896362 - 9
Management for Electrolytes Disturbances during Continuous Renal Replacement Therapy.
Baeg SI, Lee K, Jeon J, Jang HR
Electrolyte & blood pressure : E & BP 2022; (20(2)):64-75 doi:10.5049/EBP.2022.20.2.64.
PMID: 36688209 - 10
Analysis of the therapeutic effect of online haemodiafiltration on delayed methotrexate excretion combined with acute kidney injury in children: a real-world study.
Zhang B, Nie X, Xue H, et al.
BMC pediatrics 2025; (25(1)):606 doi:10.1186/s12887-025-05931-y.
PMID: 40775764 - 11
High-flux hemodialysis as rescue therapy for high-dose methotrexate toxicity: case series and clinical insights.
Tome ACN, Santos KF, Lima EQ, Ramalho RJ
Frontiers in medicine 2025; (12()):1495705 doi:10.3389/fmed.2025.1495705.
PMID: 40160322 - 12
Management of Patients with Acute Methotrexate Nephrotoxicity with High-Dose Leucovorin.
Flombaum CD, Liu D, Yan SQ, et al.
Pharmacotherapy 2018; (38(7)):714-724 doi:10.1002/phar.2145.
PMID: 29863765
This page explains how dialysis, glucarpidase, and other treatments may be used for methotrexate toxicity for informational purposes only and does not replace medical advice. Contact your oncology team or emergency services immediately for concerning symptoms.
Get notified when new evidence is published on Methotrexate toxicity.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.